Nuvicare-Urinary Tract Defense
Active substance: METHENAMINE, SODIUM SALICYLATE
TABLET · METHENAMINE 162 mg/1, SODIUM SALICYLATE 162.5 mg/1
United StatesActive
Marketing holder: NUVICARE LLC
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- METHENAMINE · 162 mg/1
- SODIUM SALICYLATE · 162.5 mg/1
Registration
- Registration number
- 84324-041
- Registration status
- Active
- Dispensing
- Over the counter
- Route
- ORAL
Sources
- product · openFDA NDC · 84324-041 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 84324-041 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 84324-041 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 84324-041 · Verified 2026-10-09 · open in source